Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SATURN: NeuroAiD in Spinal Cord Injury
NCT02537899Phase 4Completed
- Sponsor
- Moleac
- Start
- Apr 2015
- Primary completion
- Sep 2023
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of NeuroAiD in spinal cord injury (SCI), sponsored by Moleac. Started Apr 2015; status: completed.
02
Drugs
NeuroAiD
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT02537899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02537899.